Cenix BioScience

The company was founded in 1999 to provide high-throughput target discovery and validation services for academic and industry partners.

NEW YORK (GenomeWeb) – Contract research organization Cenix BioScience this week announced a research framework agreement with metabolite services and biomarker firm Metanomics Health.

NEW YORK (GenomeWeb News) – Cenix BioScience and Debiopharm Group today announced a research agreement to use Cenix's technology in support of Debiopharm's drug development efforts.

As part of an ongoing effort to support research into rare and neglected diseases, Cenix BioScience announced last week that it has struck a research agreement with the Children's Tumor Foundation, a non-profit organization focused on developing treatments for neurofibromatosis.

Cytoo will coordinate a new European consortium that will rely on the firm's micropattern array platform to develop a high-throughput approach to RNAi screening in cultured cells.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cytoo will coordinate a project announced on Monday that aims to combine high-throughput applications of RNAi with Cytoo's new cell normalization technology.

Cenix BioScience announced this week that it has signed a research agreement with Sygnis Bioscience.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Becton Dickinson announced the latest round of winners of its BD Biosciences Research Grant Program. Winners will receive $10,000 worth of research reagents for their projects.

The deal represents an expansion of an ongoing partnership between Cenix and Janssen focused on improving in vivo siRNA-based target validation methodologies in the central nervous system.

Pages

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.